Trial intelligence / Profile preview

Pharmaco-EEG for Montelukast

2016-003061-25Phase 4Completed

Sponsor
Christian Doppler Medical Center
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of montelukast in asthma and seasonal allergic rhinitis (SAR), sponsored by Christian Doppler Medical Center. Started Sep 2016; status: completed.

02

Drugs

montelukast
03

Conditions

asthmaseasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on 2016-003061-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003061-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call